Aptus Capital Advisors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-33,859
Closed -$3.7M 816
2022
Q2
$3.7M Buy
33,859
+4,835
+17% +$513K 0.1% 122
2022
Q1
$2.89M Buy
29,024
+1,845
+7% +$176K 0.07% 155
2021
Q4
$2.6M Buy
27,179
+5,166
+23% +$518K 0.08% 165
2021
Q3
$2.44M Buy
22,013
+3,936
+22% +$449K 0.06% 143
2021
Q2
$2.1M Buy
18,077
+5,686
+46% +$653K 0.06% 140
2021
Q1
$1.29M Buy
12,391
+675
+6% +$83.9K 0.05% 187
2020
Q4
$1.41M Buy
11,716
+1,872
+19% +$189K 0.06% 136
2020
Q3
$855K Sell
9,844
-234
-2% -$20.1K 0.05% 161
2020
Q2
$817K Buy
10,078
+3,116
+45% +$227K 0.05% 144
2020
Q1
$480K Buy
+6,962
New +$734K 0.04% 175

Other funds holding USPH

Aptus Capital Advisors's USPH Position: Q3 2022 in Review

Aptus Capital Advisors sold out of US Physical Therapy (USPH) in Q3 2022, closing a stake of 33,859 shares — an estimated $3.7M sold.

Aptus Capital Advisors first reported a position in USPH in Q1 2020 and held it in 10 quarters. The position peaked at $3.7M in Q2 2022. 196 funds tracked by Wall St. Rank hold USPH as of Q3 2022.

  • Aptus Capital Advisors reported no remaining US Physical Therapy position as of Q3 2022 after selling out during the quarter.
  • Aptus Capital Advisors sold 33,859 US Physical Therapy shares in Q3 2022, an estimated $3.7M.
  • Aptus Capital Advisors first reported a position in US Physical Therapy in Q1 2020 and held it in 10 quarters.
  • Aptus Capital Advisors's US Physical Therapy position peaked at $3.7M in Q2 2022.
  • 196 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2022.

Based on Aptus Capital Advisors's 13F filing for Q3 2022, filed 2 Nov 2022.